ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36125
-0.03%
Bitcoin
67,049.96
0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) News

VCYT

Veracyte (VCYT)

Veracyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCYT
DateTimeSourceHeadlineSymbolCompany
05/15/20244:04PMBusiness WireVeracyte to Participate in Upcoming Investor ConferencesNASDAQ:VCYTVeracyte Inc
05/08/20244:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCYTVeracyte Inc
05/07/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
05/07/20243:05PMBusiness WireVeracyte Announces First Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
05/06/20243:05PMBusiness Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingNASDAQ:VCYTVeracyte Inc
04/22/20244:00PMBusiness WireVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:VCYTVeracyte Inc
04/22/20247:30AMBusiness WireNew Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active SurveillanceNASDAQ:VCYTVeracyte Inc
04/16/20247:30AMBusiness WireVeracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024NASDAQ:VCYTVeracyte Inc
03/08/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/08/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/08/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/08/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/08/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/08/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/05/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/05/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/05/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/05/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
03/05/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
02/29/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
02/29/20244:22PMEdgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:VCYTVeracyte Inc
02/29/20244:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCYTVeracyte Inc
02/29/20243:40PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VCYTVeracyte Inc
02/29/20247:06AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCYTVeracyte Inc
02/27/20244:55PMBusiness WireVeracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN GuidelinesNASDAQ:VCYTVeracyte Inc
02/22/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
02/22/20243:05PMBusiness WireVeracyte Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:VCYTVeracyte Inc
02/21/20244:00PMBusiness WireVeracyte to Participate in the Raymond James 45th Annual Institutional Investors ConferenceNASDAQ:VCYTVeracyte Inc
02/13/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
02/08/20247:00AMBusiness WireVeracyte to Release Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024NASDAQ:VCYTVeracyte Inc
 Showing the most relevant articles for your search:NASDAQ:VCYT

Your Recent History

ASX
GMY
LSE
0NAS
Signaux Girod
LSE
0MTU
Source Stoxx Europe Mid ...
ASX
LTRN
ASX
GCY
Gascoyne Resources
LSE
OBOR
Starcrest Education
ASX
LHBO
LionHub
ASX
QANJOM
LSE
0K3C
Sopharma Trading Ad
ASX
ODM
Odin Metals
ASX
TYK
NASDAQ
ADBE
Adobe
LSE
SHG
Shanta Gold
NYSE
DUK
Duke Energy
LSE
0IFK
Editas Medicine
ASX
SWMKOS
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved